Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol

André Hazout, Philippe Bouchard, David B. Seifer, P. Aussage, Anne Marie Junca, Paul Cohen-Bacrie

Research output: Contribution to journal › Article › peer-review

280 Scopus citations

Fingerprint

Dive into the research topics of 'Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol'. Together they form a unique fingerprint.

Medicine & Life Sciences